Expert Answer
Quick Answer
Yes. GLP-1s raise resting heart rate by a consistent 8-12 bpm and compress heart-rate variability (HRV), per Attia and HRV specialist Joel Jamieson. Both typically normalize within about a month of stopping. It is likely vagus-nerve mediated and worth weighing if you are using one cosmetically or tracking cardiovascular fitness.
Moderate Consensus
on GLP-1 Agonists overall
In a dedicated explainer, describes a consistent 8-12 bpm rise in resting heart rate and HRV compression that normalize within about a month of discontinuation.
This is one of the more measurable and under-discussed effects of GLP-1 drugs, and Attia has covered it in a dedicated explainer. The finding: resting heart rate rises by a consistent 8-12 bpm, and heart-rate variability (HRV) - a marker of autonomic balance and recovery - gets compressed.
The mechanism is likely vagus-nerve mediated rather than a sign of cardiovascular damage, and the effect is reversible: both resting heart rate and HRV typically normalize within about a month of discontinuing the drug. HRV specialist Joel Jamieson (via Attia) independently reports the same 8-12 bpm increase and HRV compression, and raises the longer-term question of what sustained sympathetic "overdrive" costs someone using the drug for years.
Why it matters in practice: if you wear a recovery tracker, expect your readiness/HRV scores to look worse on a GLP-1 - that is the drug, not necessarily your fitness. And for someone using a GLP-1 cosmetically (to lose a modest amount of weight) rather than to treat obesity or diabetes, the resting-heart-rate cost is a real part of the trade-off worth discussing with a physician. Note this is distinct from the drugs' established cardiovascular-event benefit in higher-risk patients - heart rate up in the short term, major cardiac events down over the long term are not contradictory.
By a consistent 8-12 bpm at rest, with compressed HRV, per Attia and Joel Jamieson. It typically normalizes within about a month of stopping the drug.
It is likely vagus-nerve mediated and reversible, not a sign of damage. But Jamieson flags the open question of sustained sympathetic drive over years - discuss with your physician.
GLP-1s compress HRV alongside the resting-heart-rate rise, so recovery-tracker scores look worse. That reflects the drug's autonomic effect, not necessarily your fitness.
Precis Pro
The answer above is the whole answer — every expert's position, where they disagree, and the timecode behind each one. Nothing on this page is held back.
Pro adds
$9/mo · Cancel anytime
Full GLP-1 Agonists Consensus Report
See what all the experts agree and disagree on